Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.6600 (5.71%) ($6.0900 - $6.9000) on Tue. Jul. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 32.42% (three month average) | RSI | 73 | Latest Price | $6.6600(5.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 10.2% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BNDX(31%) BND(26%) IPO(18%) MCHI(12%) VCIT(12%) | Factors Impacting CAPR price | CAPR will decline at least -16.21% in a week (0% probabilities). XLU(-11%) UUP(-9%) UNG(-9%) GLD(-9%) EWJ(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -16.21% (StdDev 32.42%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $5.51(20.87%) | 10 Day Moving Average | $4.97(34%) | 20 Day Moving Average | $4.83(37.89%) | To recent high | -21.6% | To recent low | 32.9% | Market Cap | $131m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |